• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

47.47 -0.07 (-0.15%)
Streaming Delayed Price Updated: 12:50 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 684,057
Open 47.62
Bid (Size) 47.45 (3)
Ask (Size) 47.49 (2)
Prev. Close 47.54
Today's Range 47.00 - 47.72
52wk Range 39.97 - 72.83
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Cash-Producing Stocks We Find Risky
July 28, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know
July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade

Performance

YTD
-16.6%
-16.6%
1 Month
-10.7%
-10.7%
3 Month
+6.0%
+6.0%
6 Month
-14.3%
-14.3%
1 Year
+4.2%
+4.2%

More News

Read More
Exact Sciences Schedules Second Quarter 2025 Earnings Call
July 14, 2025
From Exact Sciences Corp.
Via Business Wire
1 Healthcare Stock for Long-Term Investors and 2 to Be Wary Of
July 14, 2025
Via StockStory
Topics Stocks
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
July 09, 2025
From Exact Sciences Corp.
Via Business Wire
Forecasting The Future: 9 Analyst Projections For Exact Sciences
July 08, 2025
Via Benzinga
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
June 25, 2025
Via Benzinga
Topics Artificial Intelligence
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down
June 17, 2025
Via StockStory
Topics Economy
A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack
June 11, 2025
Via StockStory
Topics Artificial Intelligence
3 Mid-Cap Stocks in the Doghouse
June 02, 2025
Via StockStory
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap
May 28, 2025
From Exact Sciences Corp.
Via Business Wire
Exact Sciences to Participate in June Investor Conference
May 27, 2025
From Exact Sciences Corp.
Via Business Wire
3 Low-Volatility Stocks Walking a Fine Line
May 23, 2025
Via StockStory
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
May 22, 2025
From Exact Sciences Corp.
Via Business Wire
EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion
May 16, 2025
Via StockStory
1 Healthcare Stock Worth Investigating and 2 to Ignore
May 16, 2025
Via StockStory
Topics Stocks
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
May 14, 2025
Via The Motley Fool
Exact Sciences Earns 2025 Great Place To Work® Certification™
May 12, 2025
From Exact Sciences Corp.
Via Business Wire
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
May 04, 2025
Via Benzinga
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
May 02, 2025
Via StockStory
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
May 02, 2025
Via Benzinga
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance
May 02, 2025
Via Benzinga
Exact Sciences to Participate in May Investor Conference
May 02, 2025
From Exact Sciences Corp.
Via Business Wire
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
May 02, 2025
Via Benzinga
Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars
May 01, 2025
Via StockStory

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 47.47
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 07/30/25 12:50 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 8.16B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 8B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap